Key Highlights
- Lam Research (LRCX) reached a record peak of $274.42, delivering a 262% gain over 12 months
- Fiscal third-quarter performance exceeded projections; fourth-quarter outlook surpassed Wall Street forecasts
- TD Cowen boosted its price objective to $340 from $290 while reaffirming a Buy recommendation
- Multiple firms including UBS, Stifel, RBC, Cantor Fitzgerald, and TD Cowen maintain positive ratings
- The semiconductor equipment maker has already achieved financial milestones originally projected for 2028
Lam Research (LRCX) touched a historic peak of $274.42 during Thursday’s trading session, marking the culmination of a remarkable year that saw shares gain over 262%.
Lam Research Corporation, LRCX
Data from InvestingPro shows the one-year performance at 267%, with shares trading within 1% of the 52-week peak of $273.50.
The remarkable rally has been fueled by robust financial results and multiple analyst endorsements throughout recent weeks.
Lam delivered fiscal third-quarter numbers that exceeded both Stifel’s projections and consensus estimates. The semiconductor equipment manufacturer also provided fourth-quarter guidance that beat expectations across revenue expansion and profit margins.
Executives highlighted that the company has already reached financial performance targets initially set for calendar year 2028 and later periods — well ahead of the original timeline.
Wall Street Increases Price Objectives
TD Cowen analyst Krish Sankar elevated his price objective on LRCX to $340 from $290 this Wednesday, maintaining a Buy recommendation. Sankar recognized that skeptics may cite limited room for growth following the robust June quarter guidance and premium valuation levels, yet emphasized that client demand and margin performance justify further upward revisions to estimates.
Stifel similarly maintained a Buy stance and increased its target to $325, referencing the impressive quarterly performance.
RBC Capital elevated its objective to $310, highlighting robust demand from generative AI applications and gains in market share, alongside an enhanced perspective for wafer fabrication equipment expenditure in 2026.
Cantor Fitzgerald maintained an Overweight recommendation with a $320 price objective, emphasizing an improved wafer fabrication equipment landscape extending through 2026 and 2027.
UBS affirmed a Buy recommendation, characterizing Lam’s movement into what analysts view as an AI-fueled expansion phase.
Strong Financial Foundation Supports Rally
Lam’s underlying financial metrics have remained solid throughout the stock price appreciation. The company demonstrates a flawless Piotroski Score of 9, indicating exceptional financial health, while 20 analysts have increased earnings projections during recent timeframes, per InvestingPro data.
TD Cowen’s Sankar acknowledged that critics will highlight elevated valuation multiples following the strong guidance, though the firm maintains that customer demand and profitability trends remain encouraging.
LRCX concluded Thursday’s session with approximately 4% gains, positioning shares adjacent to the newly established record high of $274.42.
